Joomla gallery by

USCIITG frontpage

  • Annual NIH Meeting in November

    The USCIITG annual meeting will be held in Betheda, MD Sunday (half day, 12-5), November 3rd, Hyatt Regency Bethesda and Monday (full day), November 4th, Natcher Center, National Institutes of Health Bethesda, Maryland

  • May in Philadelphia

    Two USCIITG sessions will be held at the American Thoracic Society Annual Meeting in Philadelphia. See the 2013 Meetings tab for more information.

  • USCIITG Winter Investigators Meeting 2014

    In conjunction with the Society of Critical Care Medicine’s 43rd Critical Care CongressJanuary 9-13, 2014, Moscone Center, San Francisco, California meeting/1stPlaceSanFranciscoCableCars.jpg

USCIITG Calendar of Events

April 2014
30 31 1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 1 2 3





USCIITG Spring Investigators Meeting


 Monday, May 19, 3-4:30 pm 

Location: TBD

In conjunction with The American Thoracic Society's 

2014 International Conference

May 16-21, 2014

San Diego, California


Seventh Annual Fall Meeting of the USCIIT Group


 Nov 12-13, 2014


Natcher Center, National Institutes of Health

Bethesda, Maryland




The U.S. Critical Illness and Injury Trials (USCIIT) Group is funded by the National Institute of General Medical Sciences (NIH) to create a clinical research framework that reduces the barriers to investigation using the same investigator-initiated, evidence-driven, inclusive approach that has proven successful in other countries. The dual missions of the USCIIT Group are to foster investigator-initiated hypothesis testing and to plan strategically at the national level. The USCIIT Group does not fund clinical trials per se, but rather promotes the development of evidence-based clinical protocols and the subsequent preparation of applications for funding to test specific hypotheses. Investigators that span the gamut of critical illness and injury specialties are involved in this collaborative effort.

It is expected that the USCIIT Group will act as a "network of networks", that is, it will not act in isolation, but will be part of a larger effort to bridge critical care trials groups world-wide. Its success will be based on collaborative leadership, non-hierarchical team culture, and open dialog among participants that will facilitate communication streams and help link new scientific knowledge with practice.